Corporate News tagged:
Drug Discovery (3)
Mar 05, 2015
New paper demonstrates formation of spontaneously active neuronal networks by stem cell derived neurons in 3D Alvetex Scaffold culture system
A recently published paper by Imogen Smith et al. demonstrates the use of the Alvetex platform to culture 3D differentiated human neural stem cells.
Feb 02, 2015
RSC book publication: Human-based systems for translational research
Read about the REPROCELL Europe CEO's newly published review of functional human tissue assays in a new book entitled Human-based systems for translational research
Jan 13, 2015
Biopta and Proteon publish new research in Journal of Cardiovascular Pharmacology
A new paper in the Journal of Cardiovascular Pharmacology describes a potential treatment for atherosclerosis.
Aug 05, 2014
Stem Cell Company REPROCELL (Japan) Acquires 3D Cell Culture Company Reinnervate (UK) and Human Tissue Supplier BioServe (USA)
Read about the Japanese regenerative medicine company REPROCELL Inc. and its acquisition of Reinnervate Ltd. (UK), and BioServe Inc. of MD, USA.
Feb 25, 2014
Scottish company creates first searchable database of human pharmacological responses in functional intact tissues
Biopta Ltd, the human tissue-based contract research organisation, today announced a major development in discovery research with the launch of the first catalog of assays based on human functional tissues.
Nov 13, 2013
Biopta collaborates with Merck to investigate in vivo cardiac effects
In a recent collaboration with Merck, Biopta conducted human functional tissue experiments to investigate the mechanisms underlying two anti-arrhythmic drugs.
Apr 23, 2013
Scottish SMEs Announce Collaboration with Universities, Industry and NHS in Establishment of a £20m Stratified Medicine Scotland Innovation Centre
Today Scotland’s First Minister Alex Salmond announced the creation of a £20M Stratified Medicine Scotland Innovation Centre (SMS-IC), at the new South Glasgow Hospitals Campus.